abstract
- Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383:2603-15. 33301246.
The BNT162b2 (BioNTech/Pfizer) vaccine had 95% efficacy against COVID-19 ≥7 days after the 2nd dose
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
authors
status
publication date
- February 2021
has subject area
- 1103 Clinical Sciences (FoR)
- 1117 Public Health and Health Services (FoR)
- BNT162 Vaccine (MeSH)
- COVID-19 (MeSH)
- COVID-19 Vaccines (MeSH)
- Humans (MeSH)
- RNA, Messenger (MeSH)
- SARS-CoV-2 (MeSH)
- Vaccines (MeSH)
published in
- ACP journal club Journal